Liraglutide Suppresses Obesity and Hyperglycemia Associated with Increases in Hepatic Fibroblast Growth Factor 21 Production in KKAy Mice. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.